Anthera Pharmaceuticals 

We are focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs.

Find out more about what we are doing for patients with Cystic Fibrosis, Systemic Lupus Erythematosus, and IgA Nephropathy:

Cystic Fibrosis
Systemic Lupus Erythematosus
IgAN

ANTH on NASDAQ

LATEST NEWS

Anthera Pharmaceuticals Announces Participation in Upcoming Healthcare Conferences. Read more

Anthera Pharmaceuticals Announces that the Blisibimod CHABLIS-SC1 Phase 3 Study Did Not Achieve the Primary Endpoint in Patients with Active Systemic Lupus Erythematosus. Read more

UPCOMING EVENTS

2016 Annual Piper Jaffray Healthcare Conference
November 30, 2016

2016 Citi Global Healthcare Conference
December 7-8, 2016

Print Friendly